|
|
TOLEROGENIC AND PATHOLOGIC INTERACTIONS BETWEEN ILCS AND T CELLS IN AUTOIMMUNITY |
| 1F31AI138389-01A1 |
GRIGG, JOHN BENJAMIN |
NIAID |
2019 |
|
|
INTRA-LYMPH NODE DELIVERY OF TOLEROGENIC MICROPARTICLES FOR MODULATING DISEASE IN A MODEL OF MULTIPLE SCLEROSIS |
| 1F31AI143204-01A1 |
GOSSELIN, EMILY A |
NIAID |
2019 |
|
|
TARGETED DEPLETION OF PROGRAMMED DEATH-1 POSITIVE CELLS, A METHOD THAT NOT ONLY STOPS AUTOIMMUNE ATTACK BUT ALSO PRESERVES ADAPTIVE IMMUNITY |
| 1R01AI139535-01A1 |
CHEN, MINGNAN |
NIAID |
2019 |
|
|
DEFINING THE ROLE OF MOLECULES UNIQUE TO ENCEPHALITOGENIC T CELLS IN MS |
| 1R01AI140741-01A1 |
LOVETT-RACKE, AMY E |
NIAID |
2019 |
|
|
MOLECULAR REGULATION OF TLR2-MEDIATED AUTOIMMUNE INFLAMMATION |
| 1R01AI141596-01 |
REYNOLDS, JOSEPH MICHAEL |
NIAID |
2019 |
|
|
NOVEL REGULATION AND TARGETING OF MACROPHAGES METABOLISM IN NEUROINFLAMMATORY DISORDERS |
| 1R01AI144004-01 |
GIRI, SHAILENDRA |
NIAID |
2019 |
|
|
CONTROLLING THE FLUX OF SPHINGOSINE-1-PHOSPHATE IN VIVO |
| 1R01AI144026-01 |
LYNCH, KEVIN R. |
NIAID |
2019 |
|
|
REGULATION OF B CELL FUNCTION IN DEMYELINATING DISEASE BY N-GLYCAN BRANCHING |
| 1R01AI144403-01 |
DEMETRIOU, MICHAEL |
NIAID |
2019 |
|
|
IMPROVING MULTIPLE SCLEROSIS PATIENT QUALITY OF LIFE USING MICRONEEDLE PATCHES TO SIMPLIFY DELIVERY OF MS DRUGS |
| 1R01AI144667-01A1 |
JEWELL, CHRISTOPHER M |
NIAID |
2019 |
|
|
TYPE I INTERFERON DYSREGULATION IN DOWN SYNDROME |
| 1R01AI150300-01 |
BOGUNOVIC, DUSAN |
NIAID |
2019 |
